Eiken Chemical Co., Ltd. (TYO:4549)

Market Cap	75.72B
Revenue (ttm)	41.22B
Net Income (ttm)	2.34B
Shares Out	32.75M
EPS (ttm)	68.34
PE Ratio	33.83
Forward PE	22.41
Dividend	58.00 (2.51%)
Ex-Dividend Date	Sep 29, 2025

Volume	21,700
Average Volume	67,845
Open	2,362.00
Previous Close	2,312.00
Day's Range	2,312.00 - 2,362.00
52-Week Range	1,972.00 - 2,568.00
Beta	0.18
RSI	38.62
Earnings Date	Oct 30, 2025

About Eiken Chemical

Eiken Chemical Co., Ltd. engages in the manufacture and sale of clinical diagnostics in Japan. It offers microbiological reagents for diagnosis of microorganism infection, such as mediums, antimicrobial susceptibility, and rapid test reagents; urinalysis test strips for occult blood, protein, and glucose; and fecal immunochemical tests reagents for screening of colorectal cancer. The company also provides immunological and serological reagents to detect and monitor infectious disease, rheumatism, inflammation, atrophic gastritis, and prostate s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1939
• Employees: 702
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4549

Financial Performance

In 2024, Eiken Chemical's revenue was 40.54 billion, an increase of 1.22% compared to the previous year's 40.05 billion. Earnings were 2.23 billion, a decrease of -15.41%.